Patents by Inventor Romi B. Singh

Romi B. Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230058942
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Application
    Filed: October 24, 2022
    Publication date: February 23, 2023
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Patent number: 11510878
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: November 29, 2022
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Publication number: 20210106537
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Patent number: 10898444
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: January 26, 2021
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Publication number: 20180344653
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Application
    Filed: January 24, 2018
    Publication date: December 6, 2018
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh